After examining a range of therapeutic drugs,we did not observe high expression of BMAL1 resulted in resistance of AML cells to commonly used chemotherapeutic drugs such as doxorubicin and daunorubicin. This evidence concerns the gene BMAL1 and acute myeloid leukemia.